Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Myriad Genetics (MYGN) Return on Assets (2016 - 2025)

Historic Return on Assets for Myriad Genetics (MYGN) over the last 15 years, with Q3 2025 value amounting to 0.57%.

  • Myriad Genetics' Return on Assets fell 4600.0% to 0.57% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.57%, marking a year-over-year decrease of 4600.0%. This contributed to the annual value of 0.12% for FY2024, which is 1100.0% up from last year.
  • Per Myriad Genetics' latest filing, its Return on Assets stood at 0.57% for Q3 2025, which was down 4600.0% from 0.47% recorded in Q2 2025.
  • Myriad Genetics' Return on Assets' 5-year high stood at 0.01% during Q1 2022, with a 5-year trough of 0.57% in Q3 2025.
  • Over the past 5 years, Myriad Genetics' median Return on Assets value was 0.12% (recorded in 2021), while the average stood at 0.16%.
  • In the last 5 years, Myriad Genetics' Return on Assets soared by 1500bps in 2021 and then tumbled by -4600bps in 2025.
  • Quarter analysis of 5 years shows Myriad Genetics' Return on Assets stood at 0.02% in 2021, then plummeted by -354bps to 0.09% in 2022, then crashed by -147bps to 0.23% in 2023, then soared by 47bps to 0.12% in 2024, then crashed by -372bps to 0.57% in 2025.
  • Its last three reported values are 0.57% in Q3 2025, 0.47% for Q2 2025, and 0.1% during Q1 2025.